Page last updated: 2024-10-30

metaproterenol and Hyperkalemia

metaproterenol has been researched along with Hyperkalemia in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"In a patient with hyperkalemic periodic paralysis, metaproterenol prevented muscular weakness and hyperkalemia in periods of rest after exercise."3.67beta-Adrenergic treatment of hyperkalemic periodic paralysis. ( Bendheim, PE; Berg, BO; Reale, EO, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bendheim, PE1
Reale, EO1
Berg, BO1

Other Studies

1 other study available for metaproterenol and Hyperkalemia

ArticleYear
beta-Adrenergic treatment of hyperkalemic periodic paralysis.
    Neurology, 1985, Volume: 35, Issue:5

    Topics: Adolescent; Humans; Hyperkalemia; Ion Channels; Male; Metaproterenol; Muscle Contraction; Paralyses,

1985